BALAXI HEALTHCARE DOMINICANA SRL — Nystatin Importer Profile
Pharmaceutical Importer · #9 buyer for Nystatin · $525.7K import value · 24 shipments · DOMINICAN REPULIC · DGFT Verified
BALAXI HEALTHCARE DOMINICANA SRL is the #9 importer of Nystatin from India with $525.7K in import value and 24 verified shipments. BALAXI HEALTHCARE DOMINICANA SRL holds a 1.3% market share in Nystatin imports based in DOMINICAN REPULIC. The company sources from 2 verified suppliers across 22 formulations shipped to 2 countries. Overall, BALAXI HEALTHCARE DOMINICANA SRL imports 3 pharmaceutical products worth $1.1M across 3 therapeutic categories.
BALAXI HEALTHCARE DOMINICANA SRL — Nystatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Nystatin to BALAXI HEALTHCARE DOMINICANA SRL?
Verified from 24 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BALAXI PHARMACEUTICALS LIMITED | $294.8K | 16 | 56.1% |
| BALAXI VENTURES LIMITED | $230.9K | 8 | 43.9% |
BALAXI HEALTHCARE DOMINICANA SRL sources Nystatin from 2 verified Indian suppliers based on 24 customs records. The primary supplier is BALAXI PHARMACEUTICALS LIMITED accounting for 56.1% of imports.
How Does BALAXI HEALTHCARE DOMINICANA SRL Compare to Nearest Nystatin Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | AVET PHARMACCEUTICALS INC | UNITED STATES | $1.0M | 20 | $50.0K |
| 1 | M/S. GITTOES PHARMACEUTICALS LTD. | UGANDA | $700.0K | 14 | $50.0K |
| 9 | BALAXI HEALTHCARE DOMINICANA SRL ★ | DOMINICAN REPUBLIC | $699.4K | 24 | $29.1K |
| 11 | MACLEODS PHARMA USA.INC | UNITED STATES | $459.4K | 54 | $8.5K |
| 12 | J. KNIPPER & COMPANY | UNITED STATES | $394.3K | 28 | $14.1K |
BALAXI HEALTHCARE DOMINICANA SRL ranks #9 among 458 Nystatin importers from India. Average shipment value of $29.1K compared to the market average of $45.4K. The closest competitors by value are AVET PHARMACCEUTICALS INC and M/S. GITTOES PHARMACEUTICALS LTD..
Where Does BALAXI HEALTHCARE DOMINICANA SRL Import Nystatin To?
Destination countries from 24 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPULIC | $294.8K | 16 | 56.1% |
| DOMINICAN REPUBLIC | $230.9K | 8 | 43.9% |
BALAXI HEALTHCARE DOMINICANA SRL imports Nystatin to 2 countries. The primary destination is DOMINICAN REPULIC receiving 56.1% of shipments worth $294.8K.
What Nystatin Formulations Does BALAXI HEALTHCARE DOMINICANA SRL Import?
| Formulation | Value | Shipments |
|---|---|---|
| METRONIDAZOLE AND NYSTATIN OVULES GSTIN-24AAACG8443J1ZK/TAX DOCUMENT NO.65/23-24 PACKING-10X10 5000 OVULES/CTNS - 10 | $50.0K | 1 |
| NYSTATIN VAGINAL OVULES 100000 IU GSTIN-24AAACG8443J1ZK/TAX DOCUMENT NO.71/23-24 PACKING-10X10 5000 OVULES/CTNS - 10 | $50.0K | 1 |
| NYSTATIN VAGINAL OVULES 100000 IU GSTIN-24AAACG8443J1ZK/TAX DOCUMENT NO.85/23-24&86/23-24 PACKING-10X10 5000 OVULES/ | $50.0K | 1 |
| METRONIDAZOLE AND NYSTATIN OVULES GSTIN-24AAACG8443J1ZK/TAX DOCUMENT NO.85/23-24&86/23-24 PACKING-10X10 5000 OVULES/ | $50.0K | 1 |
| METRONIDAZOLE AND NYSTATIN OVULES (GSTIN-24AAACG8443J1ZK/TAX INVOICE NO.140/23-24) (PACKING-10X10) (5000 OVULES/CTNS - 1 | $50.0K | 1 |
| NYSTATIN VAGINAL OVULES 100000 IU (GSTIN-24AAACG8443J1ZK/TAX INVOICE NO.140/23-24) (PACKING-10X10) (5000 OVULES/CTNS - 1 | $50.0K | 1 |
| NYSTATIN VAGINAL OVULES 100000 IU (GSTIN | $33.0K | 1 |
| METRONIDAZOLE AND NYSTATIN OVULES (GSTIN24AAACG8443J1ZK/TAX INVOICE NO.1/2425)(PACKING-10X10) (5000 OVULES/CTNS - 10X | $32.6K | 1 |
| METRONIDAZOLE AND NYSTATIN OVULES (GSTIN24AAACG8443J1ZK/TAX INVOICE NO.13/2425) (PACKING-10X10) (5000 OVULES/CTNS - 10 | $32.6K | 1 |
| METRONIDAZOLE AND NYSTATIN OVULES (GSTIN-24AAACG8443J1ZK/TAX INVOICE NO.41/24-25) (PACKING-10X10) (5000 OVULES/CTNS - 10 | $32.5K | 1 |
BALAXI HEALTHCARE DOMINICANA SRL imports 22 distinct Nystatin formulations from India. The top formulation is METRONIDAZOLE AND NYSTATIN OVULES GSTIN-24AAACG8443J1ZK/TAX with 1 shipments worth $50.0K.
Who Are the Top Buyers of Nystatin from India and How Much Does BALAXI HEALTHCARE DOMINICANA SRL Import?
India exported $20.8M worth of Nystatin through 2,442 shipments from 223 suppliers to 96 countries, serving 458 buyers globally. BALAXI HEALTHCARE DOMINICANA SRL imports $525.7K of this total, accounting for 1.3% of India's Nystatin exports with 24 shipments from DOMINICAN REPULIC. This is verified from 24 customs shipment records covering 22 distinct formulations.
What Is the Average Order Value for BALAXI HEALTHCARE DOMINICANA SRL's Nystatin Imports?
BALAXI HEALTHCARE DOMINICANA SRL's average Nystatin order value is $21.9K per consignment, based on 24 shipments totaling $525.7K. BALAXI HEALTHCARE DOMINICANA SRL is based in DOMINICAN REPULIC and ranks #9 among all Nystatin importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Nystatin to BALAXI HEALTHCARE DOMINICANA SRL?
BALAXI HEALTHCARE DOMINICANA SRL sources Nystatin from 2 verified Indian suppliers: BALAXI PHARMACEUTICALS LIMITED ($294.8K, 56.1%), BALAXI VENTURES LIMITED ($230.9K, 43.9%). This is based on 24 customs records.
How Does BALAXI HEALTHCARE DOMINICANA SRL Compare to Other Nystatin Importers?
BALAXI HEALTHCARE DOMINICANA SRL ranks #9 among 458 Nystatin importers from India with a 1.3% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($6.7M), TORRENT PHARMA INC ($4.5M), LEADING PHARMA LLC ($3.5M). BALAXI HEALTHCARE DOMINICANA SRL processed 24 shipments from DOMINICAN REPULIC.
About BALAXI HEALTHCARE DOMINICANA SRL
BALAXI HEALTHCARE DOMINICANA SRL imports 3 products worth $1.1M. Beyond Nystatin, top products include Ranitidine, Captopril. View the complete BALAXI HEALTHCARE DOMINICANA SRL profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nystatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nystatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BALAXI HEALTHCARE DOMINICANA SRL matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BALAXI HEALTHCARE DOMINICANA SRL's capped import value divided by total capped export value for Nystatin across all Indian exporters.
- 5.Verified Records: This page is backed by 24 individual customs records matching BALAXI HEALTHCARE DOMINICANA SRL importing Nystatin, covering 22 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 96+ countries, 458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nystatin Import Data for BALAXI HEALTHCARE DOMINICANA SRL
Access order-level details, pricing data, supplier connections, and competitive analysis for BALAXI HEALTHCARE DOMINICANA SRL's Nystatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BALAXI HEALTHCARE DOMINICANA SRL
Full Company Profile →
3 products · $1.1M total trade · 3 categories
BALAXI HEALTHCARE DOMINICANA SRL × Nystatin
Verified from customs records
Company Overview
Top Products by BALAXI HEALTHCARE DOMINICANA SRL
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BALAXI HEALTHCARE DOMINICANA SRL.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nystatin. For current order-level data, contact TransData Nexus.